chr1-53197092-C-A

Variant summary

Our verdict is Pathogenic. The variant received 16 ACMG points: 17P and 1B. PS3PM1PM5PP3PP5_Very_StrongBP4

The NM_000098.3(CPT2):​c.149C>A​(p.Pro50His) variant causes a missense change. The variant allele was found at a frequency of 0.000331 in 1,538,178 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV004803176: Functional studies of the p.Pro50His variant are supportive of a deleterious effect to the protein and have shown decreased stability of the mutant CPT II protein (Verderio et al., 1995)" and additional evidence is available in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P50S) has been classified as Likely pathogenic.

Frequency

Genomes: 𝑓 0.00020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00034 ( 0 hom. )

Consequence

CPT2
NM_000098.3 missense

Scores

10
6
1

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:18O:1

Conservation

PhyloP100: 4.63

Publications

32 publications found
Variant links:
Genes affected
CPT2 (HGNC:2330): (carnitine palmitoyltransferase 2) The protein encoded by this gene is a nuclear protein which is transported to the mitochondrial inner membrane. Together with carnitine palmitoyltransferase I, the encoded protein oxidizes long-chain fatty acids in the mitochondria. Defects in this gene are associated with mitochondrial long-chain fatty-acid (LCFA) oxidation disorders. [provided by RefSeq, Jul 2008]
CPT2 Gene-Disease associations (from GenCC):
  • carnitine palmitoyltransferase II deficiency
    Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health, ClinGen
  • carnitine palmitoyl transferase II deficiency, neonatal form
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • carnitine palmitoyl transferase II deficiency, myopathic form
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • carnitine palmitoyl transferase II deficiency, severe infantile form
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • encephalopathy, acute, infection-induced, susceptibility to, 4
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 16 ACMG points.

PS3
PS3 evidence extracted from ClinVar submissions: SCV004803176: Functional studies of the p.Pro50His variant are supportive of a deleterious effect to the protein and have shown decreased stability of the mutant CPT II protein (Verderio et al., 1995); SCV004812441: In vitro enzyme assays demonstrated the variant has reduced enzyme function at different temperatures indicating that this variant impacts protein function (PMID: 34063237).; SCV000632589: Experimental studies have shown that this missense change affects CPT2 function (PMID: 7711730).; SCV004847350: "In vitro functional studies provide some evidence that this variant significantly affects the CPT II catalytic activity." PMID:7711730; SCV000512762: Published functional studies in found P50H is associated with significantly reduced carnitine palmitoyltransferase II enzyme activity compared to wild type (Wataya et al. 1998)
PM1
In a topological_domain Mitochondrial matrix (size 152) in uniprot entity CPT2_HUMAN there are 15 pathogenic changes around while only 4 benign (79%) in NM_000098.3
PM5
Other missense variant is known to change same aminoacid residue: Variant chr1-53197091-C-T is described in ClinVar as Likely_pathogenic. ClinVar VariationId is 2078263.Status of the report is criteria_provided_single_submitter, 1 stars.
PP3
Multiple lines of computational evidence support a deleterious effect 9: AlphaMissense, BayesDel_addAF, BayesDel_noAF, Cadd, Eigen, MutationAssessor, PROVEAN, REVEL, REVEL [when max_spliceai, FATHMM_MKL, MetaRNN, MutationTaster was below the threshold]
PP5
Variant 1-53197092-C-A is Pathogenic according to our data. Variant chr1-53197092-C-A is described in ClinVar as Pathogenic. ClinVar VariationId is 8954.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP4
Computational evidence support a benign effect (MetaRNN=0.016327322). . Strength limited to SUPPORTING due to the PP5.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000098.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CPT2
NM_000098.3
MANE Select
c.149C>Ap.Pro50His
missense
Exon 1 of 5NP_000089.1P23786
CPT2
NM_001330589.2
c.149C>Ap.Pro50His
missense
Exon 1 of 5NP_001317518.1A0A1B0GTB8

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CPT2
ENST00000371486.4
TSL:1 MANE Select
c.149C>Ap.Pro50His
missense
Exon 1 of 5ENSP00000360541.3P23786
CPT2
ENST00000873097.1
c.149C>Ap.Pro50His
missense
Exon 1 of 6ENSP00000543156.1
CPT2
ENST00000637252.1
TSL:5
c.149C>Ap.Pro50His
missense
Exon 1 of 6ENSP00000490492.1A0A1B0GVF3

Frequencies

GnomAD3 genomes
AF:
0.000204
AC:
31
AN:
152062
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00141
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000191
Gnomad OTH
AF:
0.000479
GnomAD2 exomes
AF:
0.000173
AC:
23
AN:
132920
AF XY:
0.000207
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00185
Gnomad NFE exome
AF:
0.000182
Gnomad OTH exome
AF:
0.000246
GnomAD4 exome
AF:
0.000345
AC:
478
AN:
1386116
Hom.:
0
Cov.:
30
AF XY:
0.000319
AC XY:
218
AN XY:
684186
show subpopulations
African (AFR)
AF:
0.0000317
AC:
1
AN:
31564
American (AMR)
AF:
0.0000280
AC:
1
AN:
35738
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35720
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79234
European-Finnish (FIN)
AF:
0.00216
AC:
79
AN:
36658
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5690
European-Non Finnish (NFE)
AF:
0.000352
AC:
380
AN:
1078496
Other (OTH)
AF:
0.000294
AC:
17
AN:
57880
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
28
57
85
114
142
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000204
AC:
31
AN:
152062
Hom.:
0
Cov.:
32
AF XY:
0.000215
AC XY:
16
AN XY:
74278
show subpopulations
African (AFR)
AF:
0.0000483
AC:
2
AN:
41388
American (AMR)
AF:
0.00
AC:
0
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00141
AC:
15
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.000191
AC:
13
AN:
67990
Other (OTH)
AF:
0.000479
AC:
1
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000572
Hom.:
0
Bravo
AF:
0.000128
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ExAC
AF:
0.000146
AC:
12

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
5
-
-
not provided (5)
4
-
-
Carnitine palmitoyl transferase II deficiency, severe infantile form (4)
4
-
-
Carnitine palmitoyltransferase II deficiency (5)
3
-
-
Carnitine palmitoyl transferase II deficiency, myopathic form (3)
1
-
-
Carnitine palmitoyl transferase II deficiency, myopathic form;C1833511:Carnitine palmitoyl transferase II deficiency, severe infantile form;C1833518:Carnitine palmitoyl transferase II deficiency, neonatal form;C3280160:Encephalopathy, acute, infection-induced, susceptibility to, 4 (1)
1
-
-
Encephalopathy, acute, infection-induced, susceptibility to, 4 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.87
BayesDel_addAF
Pathogenic
0.35
D
BayesDel_noAF
Pathogenic
0.55
CADD
Pathogenic
29
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.81
D
Eigen
Pathogenic
0.89
Eigen_PC
Pathogenic
0.78
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Uncertain
0.87
D
MetaRNN
Benign
0.016
T
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Pathogenic
4.3
H
PhyloP100
4.6
PrimateAI
Uncertain
0.64
T
PROVEAN
Pathogenic
-6.8
D
REVEL
Pathogenic
0.95
Sift
Uncertain
0.0010
D
Sift4G
Uncertain
0.0050
D
Polyphen
1.0
D
Vest4
0.73
MutPred
0.92
Loss of glycosylation at P50 (P = 0.0582)
MVP
1.0
MPC
0.59
ClinPred
0.54
D
GERP RS
4.7
PromoterAI
-0.020
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.97
gMVP
0.81
Mutation Taster
=45/55
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28936375; hg19: chr1-53662764; COSMIC: COSV104682695; COSMIC: COSV104682695; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.